Gabriel Blaazer

Through the Emirati Genome Program (EGP) and related public health initiatives, Abu Dhabi is rapidly advancing its position as a global leader in genomic medicine. The Emirate is moving beyond a one-size-fits-all model towards proactive, personalised care... See more

The NHS’ most valuable asset is consultant time. Why are we not using it effectively? New analysis of consultant job plans shows direct clinical care time is falling despite record workforce growth, raising urgent questions about how the NHS plans and use... See more

As the NHS seeks to rebalance care away from hospitals and towards community-based provision, the efficiency of capital investment in acute infrastructure becomes increasingly important. Long-term demand modelling plays a central role in determining where... See more

Speaking to an audience of NHS leaders, oncology specialists and industry experts, Professor Peter Johnson, the National Clinical Director for Cancer at NHS England (pictured above, right), delivered a comprehensive keynote address at the PPP Cancer Care ... See more

On 1 October 2025, Public Policy Projects convened senior leaders across cancer care for a series of vital policy discussions. Addressing health inequalities and improving cancer outcomes for underserved communities emerged as central themes throughout th... See more